Absence of azathioprine hypersensitivity after administration of its active metabolite 6-mercaptopurine.
Schmitt
K
K
Pfeiffer
U
U
Stiehrle
H E
HE
Thuermann
P A
PA
D001379:Azathioprine / Q000008:administration & dosage / Q000009:adverse effects*; D002908:Chronic Disease; D004342:Drug Hypersensitivity / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects*; D015122:Mercaptopurine / Q000008:administration & dosage*; D008875:Middle Aged; D010328:Patch Tests; D016896:Treatment Outcome; D018366:Vasculitis, Leukocytoclastic, Cutaneous / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology
D007166:Immunosuppressive Agents; D015122:Mercaptopurine; D001379:Azathioprine